Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.365,98
-0,82%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mirum Pharmaceuticals Inc (MIRM) Mirum Pharmaceuticals Inc (MIRM) Notizie

Mirum Pharmaceuticals Inc

MIRM
25,84
0,24 (0,94%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202422:10BWMirum Pharmaceuticals to Announce First Quarter 2024..
11/4/202403:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02/4/202414:30BWMirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution)..
25/3/202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
13/3/202423:00BWMirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
09/3/202401:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
05/3/202414:00BWMirum Pharmaceuticals to Participate in Upcoming Investor..
29/2/202414:30BWHepatology Publishes Six-Year Data Demonstrating Improved..
28/2/202423:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:03BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
21/2/202422:05BWMirum Pharmaceuticals to Announce Fourth Quarter and..
10/2/202403:15BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/2/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
16/1/202422:15EDGAR2Form 8-K - Current report
16/1/202414:30BWMirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
11/1/202401:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
10/1/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2023..
03/1/202414:45BWMirum Pharmaceuticals to Present at the 42nd Annual J.P...
18/12/202322:06EDGAR2Form 8-K - Current report
18/12/202314:30BWMirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
09/12/202301:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/12/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:00BWLIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
20/11/202322:05BWMirum Pharmaceuticals to Present at the 2023 Evercore ISI..
16/11/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:00BWMirum Pharmaceuticals Presents New Data at The Liver..
10/11/202323:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
03/11/202313:30BWMirum Pharmaceuticals to Present at the 2023 UBS Biopharma..
02/11/202322:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202321:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:06EDGAR2Form 8-K - Current report
02/11/202321:05EDGAR2Form 8-K/A - Current report: [Amend]
02/11/202321:05BWMirum Pharmaceuticals Reports Third Quarter 2023 Financial..
30/10/202313:30BWMirum Pharmaceuticals to Present New Data at The Liver..
27/10/202314:45BWMirum Pharmaceuticals to Announce Third Quarter 2023..
17/10/202322:39EDGAR2Form 8-K - Current report
17/10/202322:30BWMirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI..
Apertura: 26,01 Min: 25,66 Max: 26,24
Chiusura: 25,60

La tua Cronologia

NASDAQ
MIRM
Mirum Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network